Design and Discovery of Substituted 1,3,4‐Thiadiazole–1,3,5‐Triazine Hybrids as Human Immunodeficiency Virus‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors with Anti‐SARS‐CoV‐2 and Antibacterial Activities

View at publisher Summarise with VIRAT
Authors: Saumya Singh, Kumar Saurabh Srivastava, Mukesh Kumar Kumawat, Hans Raj Bhat, Angela Corona, Enzo Tramontano, Debashis Mitra, Udaya Pratap Singh
Cited by: 0
References: 39

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

A new series of substituted 1,3,4‐thiadiazole–1,3,5‐triazine hybrids was rationally designed, synthesized, and evaluated for their antiviral and antibacterial potential. The target di‐substituted ( 9a–e ) and tri‐substituted ( 11a–e ) derivatives were obtained via a stepwise nucleophilic substitution strategy from cyanuric chloride and characterized by spectroscopic techniques. Molecular docking studies against human immunodeficiency virus‐1 reverse transcriptase (HIV‐1 RT) revealed that para ‐substituted analogs displayed superior binding within the non‐nucleoside reverse transcriptase inhibitor pocket through key hydrogen bonding, π–π stacking, and electrostatic interactions. In vitro evaluation identified compounds 11a as the most active candidate. Compound 11a exhibited 83.93% inhibition of RT activity at 1 μM, an EC 50 of 72.7 nM, and effective suppression of HIV‐1 replication in CEM–GFP T cells (85.19% p24 inhibition) with a favorable therapeutic index (TI = 471). Both compounds also demonstrated inhibition of SARS‐CoV‐2‐induced cytopathic effects in Vero E6 cells at noncytotoxic concentrations. In addition, several derivatives showed moderate to good antibacterial activity against tested bacterial strains, with SAR analysis highlighting the importance of substituent electronics and positional effects on bioactivity. Overall, this study establishes substituted 1,3,4‐thiadiazole–1,3,5‐triazine hybrids as promising multifunctional scaffolds for antiviral and antibacterial drug development.

Fields of Study & Subjects

HIV/AIDS drug development and treatment Structural and Chemical Analysis of Organic and Inorganic Compounds Synthesis and Characterization of Heterocyclic Compounds

Publication details

Journal / source
ChemMedChem
Volume
21
Issue
6
Pages
e202501109–e202501109
Publication date
27 March 2026
Language
EN